Calley Means on MAHA food dye phase-out: correcting corrupt incentives, not nanny-state regulation

Summary

Calley Means, a White House special government employee and co-founder of TrueMed, argues that the food dye phase-out announced by HHS Secretary RFK Jr. is not a regulatory overreach but a correction of what he calls decades of deliberately corrupted incentives.

The tobacco industry's food playbook

The framing starts in the early 1990s, when Philip Morris and R.J. Reynolds controlled roughly 50% of the US food supply after consolidating Kraft, Nabisco, and other major brands as smoking rates fell. Means argues those companies systematically shifted scientists from tobacco to food research, lobbied the USDA to endorse the food pyramid as a blueprint for ultra-processed consumption, and engineered hyper-addictive food products. The result: 70% of an American child's diet today is ultra-processed food, versus 15% in Japan or Italy.

The economic stakes are visible in the numbers Means cites. The US spends five times more per capita on healthcare than Spain but lives six years less. Over the past decade, he puts total government subsidies to ultra-processed food at roughly $1 trillion. More than 90% of agriculture subsidies flow to corn, soy, and meat — the core inputs of ultra-processed food — while fruits and vegetables receive 0.4%. SNAP, the $140 billion-a-year food stamp program, lists soda as its single largest purchased item, with more than 60% of benefits going to ultra-processed products.

Why food dyes specifically

Means describes the dye phase-out as the clearest starting point precisely because it is hardest to defend. The dyes are petroleum-derived — crude oil with an added molecule to produce neon colors — and are already phased out in most other countries. More damaging for the industry: Kellogg's manufactures Froot Loops with carrot and watermelon juice for the Canadian and European markets from US facilities, then makes the same product with petroleum-based dyes for domestic sale. The industry's stated rationale is consumer preference — focus groups show children reaching for brighter colors — which Means dismisses as companies citing child behavior to justify feeding them crude oil.

The cost argument doesn't hold either, he says. The reformulation is not a meaningful margin issue; the industry's own research confirms this. The real driver has been lobbying infrastructure, not manufacturing constraints.

Healthcare system incentives

Means extends the argument beyond food to the entire healthcare architecture. Pharma profits grow when patients stay sick longer. Hospitals earn more from full beds than empty ones. Insurance companies, under the medical loss ratio structure, have an incentive to raise premiums as costs rise. Pharma advertising accounts for over 50% of revenue for most news channels, which Means says produces not direct editorial censorship but a complete absence of investigative curiosity about why Americans are getting sicker.

On Ozempic specifically, his objection is structural rather than pharmacological. A Biden-era Medicare ruling would have made GLP-1 drugs the frontline treatment for any obese or overweight Medicare patient — at over $1,000 per month — with no parallel funding for diet counseling or root-cause intervention. He says he'd accept Medicare coverage for a 75-year-old who is severely diabetic and 400 pounds, but argues that making it the default first-line treatment for the broader population, including a push toward six-year-olds through the American Academy of Pediatrics, compounds the underlying problem. 35% of American teenagers are already on some form of chronic disease drug.

The political coalition and 12-year timeline

Means frames the MAHA agenda as genuinely bipartisan in substance but politically contested only because of reflexive opposition to anything associated with the Trump administration. He calls out Senator Cory Booker by name for not appearing alongside RFK Jr. when the food dye policy was announced, arguing these were traditionally left-leaning issues — reforming SNAP, removing chemical additives — that Democrats have abandoned for partisan reasons.

His timeline for meaningful change is 12 years. The leverage is electoral: millions of voters, particularly mothers, shifted toward Trump in 2024 on health issues, and Trump ran roughly 50/50 among young people and independents. Means's theory of change is that delivering visible policy wins over the next two years solidifies that voting bloc, forces Democrats to compete for it by 2028, and gradually shifts both parties toward a healthcare debate centered on preventing illness rather than managing it.

On May 22nd, the administration is scheduled to release a 100-day report on the chronic disease crisis — the first government document of its kind, Means says, to directly address environmental toxins, water quality, food quality, and sedentary lifestyle as root causes.

Independent media as infrastructure

Means credits the independent media ecosystem as a necessary precondition for all of it. Pharma's dominance of mainstream advertising budgets has, in his view, produced structural self-censorship that made these conversations impossible to scale through traditional channels. He draws a direct line from podcasts and social media to the political viability of the MAHA coalition — arguing that RFK Jr.'s credibility with voters was built almost entirely through independent platforms like Joe Rogan, not through press coverage that consistently dismissed him.

50% of teens overweight or obese, 38% pre-diabetic, life expectancy declining — those are the numbers Means says should be framing every conversation about healthcare spending, not the question of which drugs Medicare should add to its formulary next.